Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,701 | 615 | 99.6% |
| Education | $40.75 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,191 | 96 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $832.95 | 45 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $816.05 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $759.70 | 50 | $0 (2024) |
| Grifols USA, LLC | $623.26 | 24 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $586.29 | 31 | $0 (2024) |
| Mylan Specialty L.P. | $482.02 | 26 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $414.18 | 20 | $0 (2024) |
| Genentech USA, Inc. | $371.05 | 22 | $0 (2024) |
| United Therapeutics Corporation | $368.87 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,762 | 81 | AstraZeneca Pharmaceuticals LP ($213.59) |
| 2023 | $1,965 | 104 | Amgen Inc. ($194.98) |
| 2022 | $1,138 | 56 | Grifols USA, LLC ($226.47) |
| 2021 | $613.05 | 37 | Actelion Pharmaceuticals US, Inc. ($140.98) |
| 2020 | $588.39 | 43 | GlaxoSmithKline, LLC. ($128.12) |
| 2019 | $1,997 | 115 | GlaxoSmithKline, LLC. ($295.03) |
| 2018 | $1,397 | 96 | GlaxoSmithKline, LLC. ($239.00) |
| 2017 | $1,281 | 85 | United Therapeutics Corporation ($187.99) |
All Payment Transactions
617 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Pulmonology | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/26/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.66 | General |
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Genentech USA, Inc. | Alecensa (Biological), Tecentriq, Tecentriq Hybreza | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: BioOncology | ||||||
| 10/14/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.66 | General |
| 09/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,277 | 7,263 | $1.4M | $282,271 |
| 2022 | 45 | 3,969 | 8,537 | $1.6M | $354,133 |
| 2021 | 51 | 5,301 | 14,509 | $1.7M | $376,455 |
| 2020 | 46 | 4,617 | 13,489 | $1.5M | $336,215 |
All Medicare Procedures & Services
178 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 132 | 141 | $246,750 | $65,782 | 26.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 140 | 142 | $213,000 | $63,367 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 246 | $48,216 | $22,314 | 46.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 412 | 466 | $132,810 | $18,322 | 13.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 83 | 122 | $31,720 | $16,002 | 50.4% |
| 82805 | Blood gases measurement, with o2 saturation | Office | 2023 | 145 | 167 | $22,378 | $12,891 | 57.6% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 166 | 214 | $192,600 | $12,137 | 6.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 303 | 306 | $63,648 | $11,641 | 18.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 227 | 267 | $37,380 | $7,066 | 18.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 205 | 208 | $40,560 | $5,662 | 14.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 269 | 357 | $32,487 | $5,630 | 17.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 53 | 62 | $51,770 | $5,485 | 10.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 171 | 200 | $40,000 | $4,896 | 12.2% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 54 | 54 | $17,658 | $4,579 | 25.9% |
| 36600 | Artery puncture collection of blood sample | Office | 2023 | 145 | 167 | $30,895 | $3,148 | 10.2% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 45 | 45 | $55,670 | $3,075 | 5.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 33 | 33 | $25,905 | $2,897 | 11.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 239 | $9,560 | $2,524 | 26.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 24 | 24 | $14,520 | $2,163 | 14.9% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2023 | 17 | 17 | $15,385 | $2,081 | 13.5% |
| 82375 | Carboxyhemoglobin (protein) level | Office | 2023 | 145 | 153 | $13,005 | $1,847 | 14.2% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 20 | 20 | $20,000 | $1,600 | 8.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 17 | $3,400 | $1,574 | 46.3% |
| 94621 | Test for exercise-induced heart and lung stress | Office | 2023 | 16 | 16 | $8,000 | $1,523 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,256 | $1,414 | 43.4% |
About Dr. David Thornton, MD
Dr. David Thornton, MD is a Pulmonary Disease healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265472773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Thornton, MD has received a total of $10,742 in payments from pharmaceutical and medical device companies, with $1,762 received in 2024. These payments were reported across 617 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($10,701).
As a Medicare-enrolled provider, Thornton has provided services to 17,164 Medicare beneficiaries, totaling 43,798 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 178 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Pinehurst, NC
- Active Since 06/07/2006
- Last Updated 01/23/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1265472773
Products in Payments
- Prolastin-C Liquid (Biological) $566.96
- OPSUMIT (Drug) $549.10
- OFEV (Drug) $539.15
- NUCALA (Biological) $506.14
- TRELEGY ELLIPTA (Drug) $475.41
- GLASSIA (Biological) $350.77
- XYWAV (Drug) $342.00
- DUPIXENT (Biological) $321.95
- Yupelri (Drug) $321.11
- INSPIRE (Device) $292.66
- OPSUMIT MACITENTAN (Drug) $262.82
- TEZSPIRE (Biological) $260.25
- Arikayce (Drug) $251.01
- CUVITRU (Biological) $240.65
- ORENITRAM (Drug) $212.93
- ACTHAR (Biological) $189.98
- FASENRA (Drug) $171.72
- Xolair (Biological) $145.08
- Esbriet (Biological) $129.29
- YUPELRI (Drug) $126.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Pinehurst
Michael Pritchett, D.o, D.O
Pulmonary Disease — Payments: $1.4M
Dr. Scott Skibo, Md, MD
Pulmonary Disease — Payments: $315,493
Mr. Bradley Icard
Pulmonary Disease — Payments: $112,301
Francis Collins, Md, MD
Pulmonary Disease — Payments: $1,742
Russell Miller, M.d, M.D
Pulmonary Disease — Payments: $1,181